搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Variovorax paradoxus UPF0434 protein Vapar_2640 (Vapar_2640) CSB-YP512792VEM
CSB-EP512792VEM
CSB-BP512792VEM
CSB-MP512792VEM
CSB-EP512792VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD) CSB-YP512793VEM
CSB-EP512793VEM
CSB-BP512793VEM
CSB-MP512793VEM
CSB-EP512793VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP512794VEM
CSB-EP512794VEM
CSB-BP512794VEM
CSB-MP512794VEM
CSB-EP512794VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus Peroxyureidoacrylate/ureidoacrylate amidohydrolase RutB (rutB) CSB-YP512795VEM
CSB-EP512795VEM
CSB-BP512795VEM
CSB-MP512795VEM
CSB-EP512795VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus UPF0061 protein Vapar_2935 (Vapar_2935) CSB-YP512796VEM
CSB-EP512796VEM
CSB-BP512796VEM
CSB-MP512796VEM
CSB-EP512796VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus 50S ribosomal protein L16 (rplP) CSB-YP512797VEM
CSB-EP512797VEM
CSB-BP512797VEM
CSB-MP512797VEM
CSB-EP512797VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus 50S ribosomal protein L3 (rplC) CSB-YP512798VEM
CSB-EP512798VEM
CSB-BP512798VEM
CSB-MP512798VEM
CSB-EP512798VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus 10 kDa chaperonin (groS) CSB-YP512799VEM
CSB-EP512799VEM
CSB-BP512799VEM
CSB-MP512799VEM
CSB-EP512799VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus UPF0176 protein Vapar_3119 (Vapar_3119) CSB-YP512800VEM
CSB-EP512800VEM
CSB-BP512800VEM
CSB-MP512800VEM
CSB-EP512800VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus 50S ribosomal protein L6 (rplF) CSB-YP512801VEM
CSB-EP512801VEM
CSB-BP512801VEM
CSB-MP512801VEM
CSB-EP512801VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus S-adenosylmethionine synthase (metK) CSB-YP512802VEM
CSB-EP512802VEM
CSB-BP512802VEM
CSB-MP512802VEM
CSB-EP512802VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus Large-conductance mechanosensitive channel (mscL), partial CSB-YP512803VEM1
CSB-EP512803VEM1
CSB-BP512803VEM1
CSB-MP512803VEM1
CSB-EP512803VEM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP512804VEM
CSB-EP512804VEM
CSB-BP512804VEM
CSB-MP512804VEM
CSB-EP512804VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus DNA repair protein recO (recO) CSB-YP512805VEM
CSB-EP512805VEM
CSB-BP512805VEM
CSB-MP512805VEM
CSB-EP512805VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus Trans-aconitate 2-methyltransferase (tam) CSB-YP512806VEM
CSB-EP512806VEM
CSB-BP512806VEM
CSB-MP512806VEM
CSB-EP512806VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus NADH-quinone oxidoreductase subunit K (nuoK), partial CSB-YP512807VEM1
CSB-EP512807VEM1
CSB-BP512807VEM1
CSB-MP512807VEM1
CSB-EP512807VEM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus 30S ribosomal protein S15 (rpsO) CSB-YP512808VEM
CSB-EP512808VEM
CSB-BP512808VEM
CSB-MP512808VEM
CSB-EP512808VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus Putative phosphotransferase Vapar_1815 (Vapar_1815) CSB-YP512809VEM
CSB-EP512809VEM
CSB-BP512809VEM
CSB-MP512809VEM
CSB-EP512809VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus Urease accessory protein UreD (ureD) CSB-YP512810VEM
CSB-EP512810VEM
CSB-BP512810VEM
CSB-MP512810VEM
CSB-EP512810VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus Glycerol-3-phosphate dehydrogenase [NAD (P)+] CSB-YP512811VEM
CSB-EP512811VEM
CSB-BP512811VEM
CSB-MP512811VEM
CSB-EP512811VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>